Last Updated : June 6, 2011
Details
FilesGeneric Name:
Denosumab
Project Status:
Complete
Therapeutic Area:
Prevention of skeletal-related events due to bone metastases from solid tumours
Manufacturer:
Amgen Canada Inc.
Call for patient/clinician input open:
Brand Name:
XGEVA
Project Line:
Reimbursement Review
Project Number:
SR0235-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Prevention of skeletal-related events due to bone metastases from solid tumours
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation:
Files
Last Updated : June 6, 2011